miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR‐200b‐3p mitigates oxaliplatin resistance via targeting TUBB3 in colorectal cancer

Published:2020-03-11 Issue:7 Volume:22 Page:
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J Gene Med

Author:

Wu Yu‐Zhu¹^ORCID,Lin Hong‐Yue²,Zhang Yin¹,Chen Wen‐Fa¹

Affiliation:

1. Department of PharmacySecond Hospital Affiliated to Fujian Medical University Quanzhou China

2. Department of Gastrointestinal SurgeryAffiliated Quanzhou First Hospital to Fujian Medical University Quanzhou China

Publisher

Wiley

Subject

Genetics (clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgm.3178

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cancer statistics in China, 2015

3. Colorectal cancer

4. Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial

5. Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis;Gene;2024-12

2. Potential Mechanism of Tibetan Medicine Liuwei Muxiang Pills against Colorectal Cancer: Network Pharmacology and Bioinformatics Analyses;Pharmaceuticals;2024-03-27

3. Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer;Translational Oncology;2024-02

4. Enhancing wound healing and overcoming cisplatin resistance in ovarian cancer;International Wound Journal;2023-12-29

5. Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets;Non-coding RNA Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3